abstract |
The present invention relates to novel pyrimido[1,6-a]pyrimidin-6(2H)-one compounds that inhibit the activity of Lp - PLA2, processes for their preparation, compositions containing them and their therapeutic effect on Lp - PLA2 activity. Use in related diseases such as atherosclerosis, Alzheimer's disease. |